| Year |
Citation |
Score |
| 2023 |
Ning J, Chen L, Xiao G, Zeng Y, Shi W, Tanzhu G, Zhou R. The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 167: 115456. PMID 37696085 DOI: 10.1016/j.biopha.2023.115456 |
0.404 |
|
| 2023 |
Shi W, Mirza S, Kuss M, Liu B, Hartin A, Wan S, Kong Y, Mohapatra B, Krishnan M, Band H, Band V, Duan B. Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low Concentration Collagen Based Bioinks. Advanced Healthcare Materials. e2300905. PMID 37422447 DOI: 10.1002/adhm.202300905 |
0.416 |
|
| 2022 |
Sun M, Shi W, Wu Y, He Z, Sun J, Cai S, Luo Q. Immunogenic Nanovesicle-Tandem-Augmented Chemoimmunotherapy via Efficient Cancer-Homing Delivery and Optimized Ordinal-Interval Regime. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2205247. PMID 36453573 DOI: 10.1002/advs.202205247 |
0.308 |
|
| 2022 |
Tanzhu G, Chen L, Xiao G, Shi W, Peng H, Chen D, Zhou R. The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy. Cell Death Discovery. 8: 416. PMID 36220835 DOI: 10.1038/s41420-022-01206-y |
0.437 |
|
| 2022 |
Chen C, Luo L, Xu C, Yang X, Liu T, Luo J, Shi W, Yang L, Zheng Y, Yang J. Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes. Bmc Cancer. 22: 790. PMID 35850748 DOI: 10.1186/s12885-022-09898-2 |
0.391 |
|
| 2022 |
Jia W, Zhang T, Yao Q, Li J, Nie Y, Lei X, Mao Z, Wang Y, Shi W, Song W. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. Frontiers in Immunology. 13: 870458. PMID 35844587 DOI: 10.3389/fimmu.2022.870458 |
0.392 |
|
| 2021 |
Zhang X, Li X, Shi W, Ma H. Sensitive imaging of tumors using a nitroreductase-activated fluorescence probe in the NIR-II window. Chemical Communications (Cambridge, England). PMID 34318817 DOI: 10.1039/d1cc03232a |
0.336 |
|
| 2021 |
Sarnaik AA, Hamid O, Khushalani NI, Lewis KD, Medina T, Kluger HM, Thomas SS, Domingo-Musibay E, Pavlick AC, Whitman ED, Martin-Algarra S, Corrie P, Curti BD, Oláh J, Lutzky J, ... ... Shi W, et al. Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100612. PMID 33979178 DOI: 10.1200/JCO.21.00612 |
0.38 |
|
| 2020 |
Liu D, Chen Y, Wang Y, Lei M, Chen L, Liang R, Cheng Z, Shi W, Wang H, Lin L, Wang L, Lin F, Lin H, Liu W. Combination of Serum Amyloid A and C-Reactive Protein Exhibit Synergistic Effect in Angiogenesis by Inducing Inflammation and Vascular Network. Frontiers in Oncology. 10: 576207. PMID 33364190 DOI: 10.3389/fonc.2020.576207 |
0.316 |
|
| 2020 |
Jiang H, Zhou C, Zhang Z, Wang Q, Wei H, Shi W, Li J, Wang Z, Ou Y, Wang W, Wang H, Zhang Q, Sun W, Sun P, Yang S. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1. Nature Communications. 11: 5129. PMID 33046710 DOI: 10.1038/s41467-020-18860-4 |
0.421 |
|
| 2019 |
Xu W, Qu Y, Shi W, Ma B, Jiang H, Wang Y, Qu N, Zhu Y. Multiple bone brown tumor secondary to primary hyperparathyroidism: a case report and literature review. Gland Surgery. 8: 810-816. PMID 32042691 DOI: 10.21037/gs.2019.11.14 |
0.3 |
|
| 2016 |
Zhang J, Liu C, Shi W, Yang L, Zhang Q, Cui J, Fang Y, Li Y, Ren G, Yang S, Xiang R. The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer. Oncotarget. PMID 27203384 DOI: 10.18632/oncotarget.9392 |
0.435 |
|
| 2015 |
Gao X, Tang C, Shi W, Feng S, Qin W, Jiang T, Sun Y. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation. International Journal of Clinical and Experimental Pathology. 8: 12766-74. PMID 26722466 |
0.312 |
|
| 2013 |
Shi W, Ser W, Koh TS. Multiple-pathway modeling of tumor blood flow for dynamic contrast-enhanced imaging Proceedings of the 2013 Ieee Symposium On Computational Intelligence in Healthcare and E-Health, Cicare 2013 - 2013 Ieee Symposium Series On Computational Intelligence, Ssci 2013. 70-75. DOI: 10.1109/CICARE.2013.6583071 |
0.304 |
|
| 2011 |
Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, Wu H, Chowdhury PS, Russell AJ, Montgomery CP, Poulsom R, et al. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. Cancer Research. 71: 6073-83. PMID 21803743 DOI: 10.1158/0008-5472.Can-11-1704 |
0.631 |
|
| 2010 |
Zittermann SI, Capurro MI, Shi W, Filmus J. Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. International Journal of Cancer. 126: 1291-301. PMID 19816934 DOI: 10.1002/ijc.24941 |
0.367 |
|
| 2008 |
Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li JL, Harris AL. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research. 75: 144-54. PMID 17692341 DOI: 10.1016/j.mvr.2007.06.006 |
0.735 |
|
| 2007 |
Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Research. 67: 11244-53. PMID 18056450 DOI: 10.1158/0008-5472.CAN-07-0969 |
0.569 |
|
| 2006 |
Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: Cross-talk and therapeutic potentials Journal of Mammary Gland Biology and Neoplasia. 11: 41-52. PMID 16947085 DOI: 10.1007/s10911-006-9011-7 |
0.597 |
|
| Show low-probability matches. |